Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2004-01-02
2010-10-12
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S169000, C424S401000, C424S400000, C424S484000
Reexamination Certificate
active
07812010
ABSTRACT:
Formulations for topical or local administration of drugs directly to the breast or chest to produce a regional or local effect with lower systemic drug levels than when an effective amount is administered systemically are disclosed herein. In a preferred embodiment, the drug is administered to the surface of the breast, areola, or directly to the nipple. The formulations provide increased patient comfort, increased bioavailability and relatively high blood levels in the region to be treated with a reduction of side effects compared to those administered systemically. The preferred formulations contain drugs in the form of micro or nanoparticles, which may be formed of drug alone or in combination with an excipient or carrier. The excipient or carrier may modify the release rates or enhance absorption into the affected area. The drug formulation may be in the form of a cream, lotion or foam.
REFERENCES:
patent: 3921636 (1975-11-01), Zaffaroni
patent: 3927216 (1975-12-01), Witkowski et al.
patent: 4081533 (1978-03-01), Cheesman
patent: 4107288 (1978-08-01), Oppenheim et al.
patent: 4272398 (1981-06-01), Jaffe
patent: 4286587 (1981-09-01), Wong
patent: 4291028 (1981-09-01), Vorys
patent: 4292315 (1981-09-01), Vorys
patent: 4391797 (1983-07-01), Folkman et al.
patent: 4524359 (1985-06-01), Champagne
patent: 4525340 (1985-06-01), Lange et al.
patent: 4588724 (1986-05-01), Greenway, III et al.
patent: 4591496 (1986-05-01), Cohen et al.
patent: 4673405 (1987-06-01), Guittard et al.
patent: 4756907 (1988-07-01), Beck et al.
patent: 4762717 (1988-08-01), Crowly, Jr.
patent: 4826830 (1989-05-01), Han et al.
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4873092 (1989-10-01), Azuma et al.
patent: 4919937 (1990-04-01), Mauvais-Jarvis et al.
patent: 4919939 (1990-04-01), Baker
patent: 4965128 (1990-10-01), Greidanus et al.
patent: 4997653 (1991-03-01), Igarashi et al.
patent: 5057317 (1991-10-01), Iida
patent: 5066495 (1991-11-01), Moro et al.
patent: 5091185 (1992-02-01), Castillo et al.
patent: 5130137 (1992-07-01), Crowley, Jr.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5156851 (1992-10-01), Castillo et al.
patent: 5194259 (1993-03-01), Soudant et al.
patent: 5324522 (1994-06-01), Krenning et al.
patent: 5330768 (1994-07-01), Park et al.
patent: 5340585 (1994-08-01), Pike et al.
patent: 5359030 (1994-10-01), Ekwuribe
patent: 5362720 (1994-11-01), Labrie
patent: 5413797 (1995-05-01), Khan et al.
patent: 5417982 (1995-05-01), Modi
patent: 5434146 (1995-07-01), Labrie
patent: 5438040 (1995-08-01), Ekwuribe
patent: 5472704 (1995-12-01), Santus et al.
patent: 5482925 (1996-01-01), Hutsell
patent: 5482927 (1996-01-01), Maniar et al.
patent: 5494047 (1996-02-01), Van Os
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5536499 (1996-07-01), Znaiden et al.
patent: 5552160 (1996-09-01), Liversidge et al.
patent: 5580857 (1996-12-01), Oden
patent: 5614212 (1997-03-01), D'Angelo et al.
patent: 5633011 (1997-05-01), Dong et al.
patent: 5643604 (1997-07-01), Angeles Uribe et al.
patent: 5651976 (1997-07-01), Price et al.
patent: 5705170 (1998-01-01), Kong et al.
patent: 5778894 (1998-07-01), Dorogi et al.
patent: 5789442 (1998-08-01), Garfield et al.
patent: 5843509 (1998-12-01), Calvo Salve et al.
patent: 5945109 (1999-08-01), Schmidt et al.
patent: 5993856 (1999-11-01), Ragavan et al.
patent: 6071526 (2000-06-01), Schmidt et al.
patent: 6087351 (2000-07-01), Nyce
patent: 6358539 (2002-03-01), Murad
patent: 6416778 (2002-07-01), Ragavan et al.
patent: 6436428 (2002-08-01), Mahashabde et al.
patent: 6482448 (2002-11-01), Tabor
patent: 6517864 (2003-02-01), Orup Jacobsen et al.
patent: 6652874 (2003-11-01), Ragavan et al.
patent: 6743441 (2004-06-01), Sanders et al.
patent: 6908623 (2005-06-01), Deaver et al.
patent: 2002/0150605 (2002-10-01), Yui et al.
patent: 2003/0109507 (2003-06-01), Franke et al.
patent: 2003/0143278 (2003-07-01), DiPiano et al.
patent: 2003/0153585 (2003-08-01), Schreder et al.
patent: 2003/0175329 (2003-09-01), Azarnoff et al.
patent: 2004/0002503 (2004-01-01), Chang et al.
patent: 2004/0018991 (2004-01-01), Schmidt et al.
patent: 2004/0138314 (2004-07-01), Bua
patent: 2005/0101579 (2005-05-01), Shippen
patent: 2008/0153789 (2008-06-01), Dmowski et al.
patent: 2008/0299207 (2008-12-01), Martin
patent: 100 54 294 (2002-05-01), None
patent: 0 501 056 (1992-09-01), None
patent: 0 566 135 (1993-10-01), None
patent: 767 824 (1957-02-01), None
patent: 61-500914 (1986-05-01), None
patent: WO 91/12007 (1991-08-01), None
patent: WO 95/07071 (1995-03-01), None
patent: WO 95/31973 (1995-11-01), None
patent: WO 95/31974 (1995-11-01), None
patent: WO 96/00567 (1996-01-01), None
patent: WO 96/25150 (1996-08-01), None
patent: WO 96/37232 (1996-11-01), None
patent: WO 97/29735 (1997-08-01), None
patent: WO 98/11888 (1998-03-01), None
patent: WO 98/32422 (1998-07-01), None
patent: WO 99/24041 (1999-05-01), None
patent: WO 00/27372 (2000-05-01), None
patent: WO00/72883 (2000-12-01), None
patent: WO 02/17926 (2002-03-01), None
patent: WO 03/039553 (2003-05-01), None
Chan et al. Breast pain: What to do? The Hong Kong Practitioner vol. 21, Dec. 1999, p. 573-578.
Fentiman, et al., “Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial,”Br J Surg, 75(9): 845-846 (1988).
Fentiman, et al., “Studies of tamoxifen in women with mastalgia.”Br: J. Clinical Prac. Sympt. 68: 34-36 (1989).
Hinton, et al., “A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain,”Br. J. Clin. Practice40(8): 326-330 (1986).
Holland & Gateley, “Drug therapy of mastalgia. What are the options?”Drugs48(5): 709-716 (1994).
Irvin & Morrison, “Effectiveness of topical non-steroidal anti-inflammatory drugs in the management of breast pain,”J. R. Coll. Edinb. 43(3):158-159 (1998).
Leonard, et al., “Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer,”J. Clin. Oncol. 19: 4150-4159 (2001).
Mansel & Dogliotti, “European multicentre trial of bromocriptine in cyclical mastalgia,”Lancet335(868): 190-193 (1990).
Mansel, et al., “A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease,”Br. J. Surgery65(10): 724-27 (1978).
Mansel, et al., “Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease,”Lancet1(8278): 928-933 (1982).
Millet & Dirbas, “Clinical management of breast pain: a review,”Obstet. Gynecol. Survey57(7): 451-461 (2002).
Nazli, et al., “Controlled trial of the prolactin inhibitor bromocriptine (Partodel) in the treatment of severe cyclical mastalgia,”Br J Clin Pract43:322-327 (1989).
Steinbrunn, et al., “Mastalgia. Tailoring treatment to type of breast pain,”Postgraduate Medicine102(5): 183-184; 187-187; 193-194 (1997).
Terwogt, et al., “Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer,”Br. J. Cancer79:1158-1161(1999).
Unger, et al., “Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients,”Center Treat. Rev. 17: 243-246 (1990).
Colacurci, et al., “Effects of tibolone on the breast”,Eur. J. Obstet. Gynecol. Reprod. Biol., 80(2):235-8 (1998).
Lufkin and Ory, “Relative value of transdermal and oral estrogen therapy in various clinical situations”,Mayo Clin. Proc., 69(2):131-5 (1994).
Moline, “Pharmacologic strategies for managing premenstrual syndrome”,Clin. Pharm., 12(3):181-96 (1993).
Plu-Bureau, et al., “Percutaneous progesterone use and risk of breast cancer: results from a French cohort study of premenopausal women with benign breast disease”,Cancer Detect. Prev., 23(4):290-6 (1999).
Fentiman, et al., “Tamoxifen and benign breast problems.”,Lancet, 2(8567):1070-1072 (1987).
Mont
DiPiano Gerianne T.
Mays Peter Kevin
Ziemniak John
Femmepharma, Inc.
Kim Jennifer M
Pabst Patent Group LLP
LandOfFree
Pharmaceutical preparations for treatments of diseases and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparations for treatments of diseases and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparations for treatments of diseases and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4193028